Details of treatment-related difficulties in men with anti-N-methyl-D-aspartate receptor encephalitis. (Q48306929)

10 February 2018

title

Details of treatment-related difficulties in men with anti-N-methyl-D-aspartate receptor encephalitis. (English)

1 reference

10 February 2018

11

Susumu Kusunoki

1 reference

10 February 2018

Hikaru Sakamoto

1

1 reference

10 February 2018

Makito Hirano

2

1 reference

10 February 2018

Makoto Samukawa

3

1 reference

10 February 2018

Shuichi Ueno

4

1 reference

10 February 2018

Shunji Maekura

5

1 reference

10 February 2018

Harutoshi Fujimura

6

1 reference

10 February 2018

Motoi Kuwahara

7

1 reference

10 February 2018

Yukihiro Hamada

8

1 reference

10 February 2018

Chiharu Isono

9

1 reference

10 February 2018

Keiko Tanaka

10

1 reference

10 February 2018

Yusaku Nakamura

12

1 reference

10 February 2018

publication date

1 November 2012

1 reference

10 February 2018

published in

European Neurology

1 reference

10 February 2018

volume

69

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

page(s)

21-26

1 reference

10 February 2018

Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis

cites work

1 reference

Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents

21 January 2018

1 reference

21 January 2018

The writing on the wall

1 reference

Testicular teratoma and anti-N-methyl-D-aspartate receptor-associated encephalitis

21 January 2018

1 reference

Pearls & Oy-sters: electroconvulsive therapy in anti-NMDA receptor encephalitis

21 January 2018

1 reference

Psychiatric manifestations of anti-NMDA receptor encephalitis in a man without tumor.

21 January 2018

1 reference

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

21 January 2018

1 reference

Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke.

21 January 2018

1 reference

NR2 antibodies: risk assessment of transient ischemic attack (TIA)/stroke in patients with history of isolated and multiple cerebrovascular events.

21 January 2018

1 reference

Roles of neuronal nitric oxide synthase, oxidative stress, and propofol in N-methyl-D-aspartate-induced dilatation of cerebral arterioles.

21 January 2018

1 reference

Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study

21 January 2018

1 reference

Suppression of synaptic plasticity by cerebrospinal fluid from anti-NMDA receptor encephalitis patients.

21 January 2018

1 reference

Joint contracture following prolonged stay in the intensive care unit

21 January 2018

1 reference

Coexistence of up-regulated NMDA receptor 1 and glutamate on nerves, vessels and transformed tenocytes in tendinopathy.

21 January 2018

1 reference

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma

21 January 2018

1 reference

N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes

21 January 2018

1 reference

Prolonged Follow-up and CSF Antibody Titers in a Patient With Anti-NMDA Receptor Encephalitis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000342023

1 reference

10 February 2018

PubMed ID

23128856

1 reference

10 February 2018